Akebia Therapeutics Inc (STU:AX9)
€ 1.008 0.025 (2.54%) Market Cap: 213.24 Mil Enterprise Value: 214.06 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Q1 2019 Akebia Therapeutics Inc Earnings Call Transcript

May 09, 2019 / 01:00PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Akebia Therapeutics Q1 Fiscal Year 2019 Financial Results and Business Highlights Conference Call. As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference. Kristen Sheppard, Vice President of Investor Relations. You may now begin.

Kristen K. Sheppard
Akebia Therapeutics, Inc. - VP of IR

Thank you. Good morning, and thank you for joining us to discuss Akebia's first quarter 2019 financial results and our recent business highlights. The press release containing the company's financial results for the first quarter was issued earlier this morning and is also available on our Investor Relations website. For your convenience, an audio replay of today's call will also be available on our website shortly after we conclude today's webcast. Joining our call are John Butler, President and Chief Executive Officer of Akebia; and Jason Amello, Chief Financial Officer.

Before we begin, I would like to remind everyone that this conference call includes

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot